Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal phosphate absorption system encompasses the pathways and regulatory mechanisms involved in the uptake of dietary phosphate in the small intestine. It relies on both active (transcellular) and passive (paracellular) transport, mediated by transporters like NaPi2b (SLC34A2) and influenced by factors like NHE3. Hormones such as vitamin D, PTH, and FGF23 tightly regulate this system to maintain phosphate homeostasis. While targeted for treating hypophosphatemia and other conditions, dysregulation can lead to hyperphosphatemia and related complications.
Active and passive transport of phosphate across the intestinal epithelium, regulated by hormones and influenced by dietary intake.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal Phosphate Absorption System (N/A).